Article révisé par les pairs
Titre :
  • Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.
Auteur : El Saghir, Nagi S ; Tfayli, Arafat ; Hatoum, Hassan A ; Nachef, Zahi ; Dinh, Phuong ; Awada, Ahmad
Informations sur la publication : Critical reviews in oncology/hematology, 80, 3, (page 433-449)
Statut de publication : Publié, 2011-12
Sujet CREF : Cancérologie
Mots-clés : Anthracyclines
Anti-angiogenesis
Anti-EGFR
Anti-ErbB2 targeted therapy
Anti-RANKL
Aromatase inhibitors
Bisphosphonates
Chemotherapy
Endocrine treatment
Metastatic breast cancer
Palliation
PARP inhibitors
Survival
Taxanes
Mots-clés MeSH : Angiogenesis Inhibitors -- therapeutic use
Antineoplastic Agents, Hormonal -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- classification -- secondary -- therapy
Female
Humans
Molecular Targeted Therapy
Palliative Care
Poly(ADP-ribose) Polymerases -- antagonists & inhibitors
Prognosis
RANK Ligand -- antagonists & inhibitors
Receptor, Epidermal Growth Factor -- antagonists & inhibitors
Receptor, erbB-2 -- metabolism
Recurrence
Note : Journal Article
Review
SCOPUS: re.j
Langue :
  • Anglais
Identificateurs : urn:issn:1040-8428 
info:doi/10.1016/j.critrevonc.2011.01.010
info:pii/S1040-8428(11)00021-7
info:pmid/21330148